Guest Writer
While continuation vehicles may not always be the optimal solution for sponsors and LPs, other attractive liquidity solutions are gaining in popularity, writes Todd Miller, partner at W Capital Partners.
Given the uncertainties that remain in the macro environment, private equity’s resilience remains key, writes Nils Rode, chief investment officer at Schroders Capital.
Emerging managers should not be surprised when they are expected to provide reporting and transparency on a par with larger competitors, writes Jeff Gendel, principal at Gen II Fund Services.
GPs can get much done to head off investor concerns before sitting at the negotiating table, writes communications adviser Joshua Rosen.
Private equity investment in the sector is attracting increasing attention from regulatory bodies as oversight intensifies at both federal and state levels, says Kirkland & Ellis's Dennis Williams.
Most GPs tout their sector expertise, but Avista Healthcare Partners’ David Burgstahler asserts that such expertise needs to focus on specific subsectors to pay real dividends.
The future of private equity in healthcare belongs to firms that can cultivate a specialist approach but still pivot to promising subsectors, believes Linden Capital Partners’ Tony Davis.
Easier access points, better education and a good dose of patience are what is required to unlock the potential of the private wealth channel, says iCapital’s managing director Kunal Shah.
The democratization of private equity is about expanding access to the asset class by solving the structural and operational barriers to investing, says Neuberger Berman’s Peter von Lehe.
Private equity firms are establishing dedicated education programs to meet the needs of individual investors and the wealth management community, writes Jon Yarker.